Epidemiological studies suggest that persistent and cumulative environmental toxicants such as PCBs and dioxins may affect growth and development through thyroid impairment 7) , and other epidemiological studies show a negative relationship between PCB concentrations and T 4 levels in milk and plasma from mothers 8) . In one study of developing rats and young mice, short-term (4 consecutive days) exposure to 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153), a di-ortho-substituted non-coplanar congener, at doses ranging from 0.3-300 mg/kg/d for rats and 0.9-90 mg/kg/d for mice induced dose-related decreases in serum T 4 concentrations and achieved an 80% maximal reduction T 4 in levels with respect to controls 9) . In rat offspring following PCB 153 exposure (gestation day, GD, 10-16, 16-64 mg/kg/d), T 4 levels were significantly decreased in a dose-dependent manner 10) . These human and animal studies indicate that PCB exposure might affect thyroid development and function. Although a number of studies on PCB mixtures in laboratory animals have been reported, detailed toxicity profiles of individual PCB congeners are not yet available. In this regard, PCB 153 has been detected in wildlife, as well as in human plasma and breast milk, and thus can be an appropriate biomarker for PCB exposure 11) .
Previous studies have found that prenatal exposure to PCBs causes a decrease in thyroid hormone levels in combination with growth retardation in rat offspring 10, 12, 13) . However, our recent study demonstrated that in utero exposure to PCB 153 at relatively high levels (GD 10-16, 16-64 mg/kg/d) may alter the plasma thyroid hormone levels in rat offspring to some extent but does not affect their somatic growth or growth-related hormonal parameters, such as growth hormone and insulin growth factor-I 14) . In another rat study, plasma T 4 level was reduced in a dose-dependent manner by exposure from GD 6 through postnatal day (PND) 21 to Aroclor 1254 (0, 1, 4, and 8 mg/kg), a mixture of PCBs, but body weights of the dams and their pups were not affected at any dose 15) . In the current study, we assessed the effects of in utero exposure to PCB 153 on F 1 offspring, following orally administered PCB 153 once daily to pregnant female rats on GD 10-16, and we examined somatic and longitudinal growth associated with the pituitary-thyroid axis as well as thyroid functions.
Materials and Methods

Chemicals and experimental animals
PCB 153 and corn oil were obtained from AccuStandard, Inc. (New Haven, CT, USA, Lot#: 070203MT-AC, the purity (100%) was measured using gas chromatography-mass spectrometry analysis according to the manufacturer's certificate of analysis) and Wako Pure Chemical Industries, Ltd. (Osaka, Japan), respectively. A total of 30 pregnant (GD 3) female rats (Crj: CD (SD) IGS strain, 9 wk old) was purchased from Charles River Japan, Inc. (Kanagawa, Japan). The presence of a copulatory plug defined GD 0. Rats were acclimated on GD 3-9; they were housed individually and maintained under controlled temperature (23 ± 1˚C) and humidity (55 ± 5%) on a 12-h light (08:00-20:00)/12-h dark cycle throughout the study. A standard laboratory diet (CE-2, Clea Japan, Inc., Tokyo, Japan) and drinking water were available ad libitum. All procedures using animals were approved by the National Institute of Occupational Safety and Health, Japan (JNIOSH) Institutional Animal Care and Use Committee and were in accordance with JNIOSH Guidelines for the Care and Use of Laboratory Animals.
Experimental design
Dams were randomly divided into three groups (10 pregnant females per group) and weighed once daily from GD 3 through PND 20 (except for GD 4 and 5). The PCB 153-exposed groups were treated orally from GD 10 to 16 (between 08:30 and 09:30 h) with a single dose of PCB 153 (1 or 4 mg/kg/d) in corn oil vehicle (4 ml/kg of body weight); the control group was given the same amount of corn oil during the same period. In our previous study, the dose range and dosing period were selected according to those of Ness et al. (1993) , who chose those doses upon consideration of their magnitude of acute toxicity 10) . PCB 153 (16-64 mg/kg/d) alters the plasma thyroid hormone levels in rat pups 10, 14) . To better determine the toxicological impact of in utero PCB 153 exposure on the offspring, lower dosages were selected in the present study. During the exposure period, we recorded maternal body weights and noted any clinical signs or abnormal behavior that may have resulted from toxic effects. For each dam, gestational duration as well as weight during gestation and lactation was recorded. Dams were checked daily for births before 10:00, and the day on which pups were first observed was designated as PND 0. The number of live births and the weight of each live pup on PND 1 were recorded. The litter size was standardized to 10 (five males and five females when possible) between 10:00 and 11:00 h on PND 7 (1 wk of age). Litters with a total of ten or fewer pups were not culled regardless of the sex ratio. Culled pups were used for analysis at 1 wk of age. On PND 21 (3 wk of age), the remaining offspring were weaned, and thereafter males and females were housed in separate stainless steel cages by litter. One male and one female offspring from each dam were randomly selected and sacrificed at 3 and 9 wk of age when possible. Body length, tail length, and anogenital distance (AGD) (in mm) were measured with a digital caliper (Mitutoyo, Kanagawa, Japan). The ratio of AGD to the cube root of body weight (AGD index) was calculated. While each rat was under anesthesia, selected organs were carefully removed and weighed. The ratio of each individual organ weight to body weight was also calculated.
Hormone determinations
Selected offspring were euthanized by decapitation (1-wk-old, cooled on ice) or ether inhalation (3-and 9-wkold, postcaval vein), and blood was collected from the euthanized animal for hormone analysis. Plasma samples were obtained by centrifugation at 4˚C and stored at -20˚C until analysis. Levels of plasma T 4 and tri-iodothyronine (T 3 ) were determined by a time-resolved fluoroimmunoassay (reagents for both T 4 and T 3 were from PerkinElmer, Waltham, MA, USA). Plasma thyroid-stimulating hormone (TSH) concentrations were determined by enzyme immunoassay (GE Healthcare UK Ltd., Little Chalfont, Buckinghamshire, UK). Time-resolved fluorescence and absorbance were measured by a multi-label counter (VICTOR 2 , PerkinElmer). All hormones were assayed according to the manufacturer's instructions.
TSH challenge test
The PCB 153-treated and control groups of both sexes at 9 wk of age were injected with bovine TSH (SigmaAldrich Corp., St. Louis, MO, USA) ip at 25.0 mIU/5 µl/g body weight. Blood samples were collected from the postcaval vein under euthanasia by ether inhalation at 6 h after bovine TSH administration; plasma samples were obtained by centrifugation at 4˚C and then stored at -20˚C until analysis. Plasma T 4 concentrations were measured as described above, and they were compared with corresponding basal (intact group) T 4 concentrations.
Statistical analysis
Analysis of variance followed by Dunnett's test was used to analyze for effects of treatment between the PCB 153-exposed groups and the corresponding control group (significance at p<0.05). Table 1 shows the number of dams and their offspring used for examinations in each group. In the 4 mg/kg/d PCB 153-treated group, one pregnant dam did not deliver and was excluded from subsequent analyses. No significant differences were observed between the control group and the PCB 153-treated groups in the duration of the gestational period or in the number of live births per litter on PND 1. Figure 1 shows maternal body weight changes during gestation (A) and lactation (B). Body weight changes among groups showed a similar pattern during both gestation and lactation periods. We found no significant differences in dam weight gain among the groups from GD 10 through GD 21, or between control and PCB 153-treated groups during gestation.
Results
Body and organ weights Dams
Offspring Table 2 shows developmental parameters for the male offspring. We found no statistically significant differences between control and PCB 153-treated groups in the following parameters at 1, 3 or 9 wk of age: body weight, body length, tail length, liver weight, kidney weight, testis weight, prostate weight, seminal vesicle weight, the ratio of organ weight to body weight, AGD, or AGD index. Table 3 shows developmental parameters for the female offspring. We found no statistically significant differences between control and PCB 153-treated groups in the following parameters at 1, 3 or 9 wk of age: body weight, body length, tail length, liver weight, kidney weight, ovary weight, the ratio of organ weight to body weight, AGD, or AGD index. 
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Hormone concentrations
In males, no significant differences were observed in plasma T 4 or TSH concentrations among the offspring of the treatment groups at 1, 3 or 9 wk of age (Table 4) . At 1 wk of age, plasma T 3 levels were higher among the PCB 153-treated groups compared with the control, and the effect was dependent on the dose of PCB 153, but this was not the case for the 3-and 9-wk groups (Table 4) . In females, no significant differences were observed in plasma T 4 , T 3 or TSH concentrations among the offspring of the treatment groups at any age (Table 5) . We found no statistically significant differences between control and PCB 153-treated dams in plasma T 4 , T 3 or TSH concentrations on the day of sacrifice (the day of weaning) (data not shown).
TSH challenge test
No treatment-related differences were observed in the relative T 4 increase in response to exogenous TSH in all groups of both sexes. In male offspring, plasma T 4 levels in the control, 1 and 4 mg/kg/d groups increased significantly by 159%, 126% and 137%, respectively, compared with the corresponding basal values. Likewise, in female offspring, plasma T 4 levels increased significantly by 179%, 151% and 170%, respectively (Fig. 2) .
Discussion
PCB 153 is one of the most prevalent PCB congeners in human tissues 16) , and PCB 153 exposure has been associated with reproductive toxicity and developmental toxicity. In a goat study, low-dose exposure to PCB 153 during gestation affected parameters related to the hypothalamic-pituitary-testis axis and resulted in DNA damage in sperm 17) . In an in vitro study, several PCBs adversely affected preimplantation embryo development in rabbits 18) . Previous epidemiological studies have shown inconsistent results and have not completely resolved whether prenatal and lactational exposure to PCBs affects thyroid status associated with somatic growth. In pregnant women, a significant negative correlation has been found between dioxin and PCB congeners in milk and plasma thyroid hormones; by contrast, newborn infants show higher TSH levels at higher levels of dioxin exposure, suggesting potentially negative effects of PCBs and dioxins on growth and development 8) . In addition, PCBs and dioxins may affect growth and development through thyroid impairment in mother-infant pairs 7) . These reports thus suggest that the effects of PCBs on human development are inconsistent and equivocal.
In our previous study, we examined that the effect of in utero exposure to PCB 153 in rats with identical dosing periods using higher doses (16 and 64 mg/kg/d). These results suggest that in utero exposure to PCB 153 decreases neonatal thyroid hormone levels in rat offspring to some extent but does not affect somatic growth or its related hormonal parameters 14) . The present study was conducted to determine effects of in utero exposure to lower doses of PCB 153 on postnatal development and thyroid functions in rat offspring. There were no significant differences in somatic, longitudinal and organ growth at any dose or any age (Tables 2, 3) .
AGD has been used as a common index of reproductive and developmental toxicity because it sensitively reflects the developmental status of the external genital system in rodents. The use of "the ratio of AGD to the cube root of body weight" (AGD index) has been proposed as a more accurate measurement of AGD 19) . We found no differences in the AGD index or in weights of The ratio of organ weight to body weight (%). e AGD index (mm/g 1/3 ) (the ratio of anogenital distance to the cube root of body weight).
reproductive organs and accessory glands among treatment groups of both sexes. These results suggest that these outcomes are unaltered in rat offspring following in utero PCB 153 exposure, leading to the conclusion that genital development remains intact in offspring. Further molecular biological testing may be useful to detect the potential negative impact of PCB congener exposure on androgenic status in testicular development in the offspring. We found that exposure to PCB 153 increased plasma T 3 levels in a dose-dependent manner only in the 1-wkold male offspring, and it did not affect other ages of male offspring or any ages of female offspring (Tables 4, 5) . Serum T 4 , free T 4 , and T 3 concentrations in adult rats exposed to PCB 153 (3,000 µg/kg) were significantly lower than those in the vehicle controls 20) . However, two previous studies reported slightly different results. One study found that in utero exposure to PCB 153 (GD 10-16) reduced serum T 4 levels in a dose-dependent manner at weaning, although T 3 and TSH levels were unaffected 10) . Likewise, in another study, plasma T 4 levels in PCB 77-or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)- a Values are mean ± SEM, respectively, for the number of offspring in parentheses. b -, not examined. There were no significant differences for any groups. exposed (GD 10-16) 3-wk-old female pups were significantly depressed, whereas T 3 and TSH levels were unchanged 21) . We are currently unable to explain the differences in offspring T 3 levels observed by Ness et al. 10) and Seo et al. 21) . In the present study, we found no differences in T 3 levels at 3 or 9 wk of age, indicating that the observed increase in T 3 levels of 1-wk-old males may not be biologically significant. Sensitivity to PCB or TCDD perinatal exposure affected males more severely than females [22] [23] [24] [25] . Further studies of prenatal PCB exposure will establish whether these chemical substances can contribute to gender-related or gender-specific toxicity. Although possible molecular mechanisms explaining PCB-induced thyroid hormone depression have been reviewed 26) , the impact and effects of each PCB in causing thyroid hormone defects have not been clarified. PCB 153, a non-coplanar congener, shows little or no binding to the aryl-hydrocarbon receptor and appears to act independently of this receptor to disrupt thyroidal homeostasis. Studies on the effects of PCB 153 on the regulation of deiodinases, T 4 -uridine diphosphate-glucuronyltransferase, T 4 transporter, and transthyretin may help elucidate these toxicologic mechanisms. A TSH challenge test was performed to better determine thyroid function of PCB-exposed animals. Plasma T 4 levels were significantly elevated after exogenous TSH administration in the PCB 153-exposed groups, similar to the elevation seen in the control group (Fig. 2) , suggesting that PCB 153 exposure did not affect the synthesis and release of thyroid hormone in offspring in this study.
Thyroid hormones play a pivotal role in normal growth, neuronal development, and metabolism [27] [28] [29] . It is thought that chemical exposure is more likely to create endocrine disturbances in the embryo and/or neonate than in the adult. An epidemiological study suggests that toxicants, such as PCBs and dioxins, which are persistent and cumulative compounds in the environment, may affect growth and development by impairing thyroid function 7) . In the present study, developmental parameters and thyroidrelated landmarks were normal in offspring following exposure of dams to PCB 153 (GD 10-16, 1-4 mg/kg/d), suggesting that somatic growth and thyroid status in rat offspring remains intact.
